113
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Apoptosis-Mediated Chemoprevention by Different Ratios of Fish Oil in Experimental Colon Carcinogenesis

, , &
Pages 220-230 | Received 13 Apr 2015, Accepted 22 Apr 2016, Published online: 18 May 2016

References

  • Sandouk F, A Jerf F, Al-Halabi MH. Precancerous lesions in colorectal cancer. Gastroenterol Res Pract 2013;2013:457901.
  • Elmore S. Apoptosis. A review of programmed cell death. Toxicol Pathol 2007;35:495–16.
  • Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001;104:487–91.
  • Bennett MW, O'Connell J, Houston A, Kelly J, O'Sullivan GC; Collins JK; Shanahan F. Fas ligand upregulation is an early event in colonic carcinogenesis. J Clin Pathol 2001;54:598–4.
  • Asanuma K, Tsuji N, Endoh T, Yagihashi A, Watanabe N. Survivin enhances Fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells. J Immunol 2004;172:3922–29.
  • Harris MH, Thompson CB. The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability. Cell Death Differ 2000;7:1182–91.
  • Fulda S, Galluzzi L, Kroemer G. Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 2010;9:447–64.
  • Wang C, Youle RJ. The role of mitochondria in apoptosis. Annu Rev Genet 2009;43:95–118.
  • Berquin IM; Edwards IJ; Chen YQ. Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett 2008;269:363–77.
  • Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med 2008;233:674–88.
  • Sarotra P, Sharma G, Kansal S, Negi AK, Aggarwal R, Sandhir R, et al. Chemopreventive effect of different ratios of fish oil and corn oil in experimental colon carcinogenesis. Lipids 2010;45:785–98.
  • Sharma G, Rani I, Kansal S, Bhatnagar A, Agnihotri N. Alterations in mitochondrial membrane in chemopreventive action of fish oil. Cancer Invest 2013;31:231–40.
  • Latham P, Lund EK, Johnson IT. Dietary n-3 PUFA increases the apoptotic response to 1,2-dimethylhydrazine, reduces mitosis and suppresses the induction of carcinogenesis in the rat colon. Carcinogenesis 1999;20:645–50.
  • Sanders LM, Henderson CE, Hong MY, Barhoumi R, Burghardt RC, Wang N, et al. An increase in reactive oxygen species by dietary fish oil coupled with the attenuation of antioxidant defenses by dietary pectin enhances rat colonocyte apoptosis. J Nutr 2004;134:3233–38.
  • Freshney RI. Culture of animal cells: A manual of basic technique; Wiley Liss, New York, USA, 3rd edition, 1994.
  • Somma F, Tuosto L, Gilardini Montani MS, Di Somma MM, Cundari E, Piccolella E. Engagement of CD4 before TCR triggering regulates both Bax- and Fas (CD95)-mediated apoptosis. J Immunol 2000;164:5078–87.
  • Van Beek-Harmsen BJ, Van der Laarse WJ. Immunohistochemical determination of cytosolic cytochrome C concentration in cardiomyocytes. J Histochem Cytochem 2005;53:803–7.
  • Sun SN, Jia WD, Chen H, Ma JL, Ge YS, Yu JH, Li JS. Docosahexaenoic acid (DHA) induces apoptosis in human hepatocellular carcinoma cells. Int J Clin Exp Pathol 2013;6:281–89.
  • Gu Z, Suburu J, Chen H, Chen YQ. Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention. Biomed Res Int 2013;2013:1–10.
  • Park JM, Kwon SH, Han YM, Hahm KB, Kim EH. Omega-3 Polyunsaturated Fatty Acids as Potential Chemopreventive Agent for Gastrointestinal Cancer. J Cancer Prev 2013;18:201–08.
  • Sarrabayrouse G, Synaeve C, Leveque K, Favre G, Tilkin-Mariamé AF. Statins stimulate in vitro membrane FasL expression and lymphocyte apoptosis through RhoA/ROCK pathway in murine melanoma cells. Neoplasia 2007;9:1078–90.
  • O'Callaghan G. Fas ligand expression and tumour immune evasion: the role of prostaglandin E2 and the EP1 receptor; PhD Thesis, University College Cork, 2013.
  • Hashemi M, Fazaeli A, Ghavami S, Eskandari-Nasab E, Arbabi F, Mashhadi MA, et al. Functional polymorphisms of FAS and FASL gene and risk of breast cancer - pilot study of 134 cases. PLoS One 2013;8:e53075.
  • Shiraki K, Tsuji N, Shioda T, Isselbacher KJ, Takahashi H. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas. Proc Natl Acad Sci U S A 1997;94:6420–25.
  • Okada K, Komuta K, Hashimoto S, Matsuzaki S, Kanematsu T, Koji T. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by Fas counterattack in human colorectal carcinoma and its correlation with prognosis. Clin Cancer Res 2000;6:3560–64.
  • Wang W, Zheng Z, Yu W, Lin H, Cui B, Cao F. Polymorphisms of the FAS and FASL genes and risk of breast cancer. Oncol Lett 2012;3:625–28.
  • Butler LM, Hewett PJ, Butler WJ, Cowled PA. Down-regulation of Fas gene expression in colon cancer is not a result of allelic loss or gene rearrangement. Br J Cancer 1998;77:1454–59.
  • Wajant H. The Fas signaling pathway: more than a paradigm. Science 2002;296:1635–36.
  • Kim A, Ueda Y, Naka T, Enomoto T. Therapeutic strategies in epithelial ovarian cancer. J Exp Clin Cancer Res 2012;31:14.
  • Sarrabayrouse G, Synaeve C, Leveque K, Favre G, Tilkin-Mariamé A.F. Statins stimulate in vitro membrane FasL expression and lymphocyte apoptosis through RhoA/ROCK pathway in murine melanoma cells. Neoplasia 2007;9:1078–90.
  • Das H, Koizumi T, Sugimoto T, Chakraborty S, Ichimura T, Hasegawa K, et al. Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR. Br J Cancer 2000;82:1682–88.
  • Gratas C, Tohma Y, Barnas C, Taniere P, Hainaut P, Ohgaki H. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer. Cancer Res 1998;58:2057–62.
  • Viard-Leveugle I, Veyrenc S, French LE, Brambilla C, Brambilla E. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma. J Pathol 2003;201:268–77.
  • Bullani RR, Wehrli P, Viard-Leveugle I, Rimoldi D, Cerottini JC, Saurat JH, et al. Frequent downregulation of Fas (CD95) expression and function in melanoma. Melanoma Res 2002;12:263–70.
  • Hahne M, Rimoldi D, Schröter M, Romero P, Schreier M, French LE, et al. Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science 1996;274:1363–66.
  • Töpfer K, Kempe S, Müller N, Schmitz M, Bachmann M, Cartellieri M, et al. Tumor evasion from T cell surveillance. J Biomed Biotechnol 2011;2011:918471.
  • Hofmanová J, Vaculová A, Kozubík A. Polyunsaturated fatty acids sensitize human colon adenocarcinoma HT-29 cells to death receptor-mediated apoptosis. Cancer Lett 2005;218:33–41.
  • Yano M, Kishida E, Iwasaki M, Kojo S, Masuzawa Y. Docosahexaenoic acid and vitamin E can reduce human monocytic U937 cell apoptosis induced by tumor necrosis factor. J of Nutr 2000;130:1095–1.
  • Serini S, Piccioni E, Merendino N, Calviello G. Dietary polyunsaturated fatty acids as inducers of apoptosis: implications for cancer. Apoptosis 2009;14:135–52.
  • Zech B, Köhl R, von Knethen A, Brüne B. Nitric oxide donors inhibit formation of the apaf-1/caspase-9 apoptosome and activation of caspases. Biochem J 2003;371:1055–64.
  • Hirose Y, Yoshimi N, Suzui M, Kawabata K, Tanaka T, Mori H. Expression of Bcl-2, Bax and Bcl-XL proteins in azoxymethane-induced rat colonic adenocarcinomas. Mol Carcinog 1997;19:25–30.
  • Chen GG, Lee JF, Chan UP, Xu H, Ip PC, Lau WY. Increased apoptosis in infiltrating mononuclear cells of colorectal cancer: a mechanism for tumor escape. Arch Pathol Lab Med 2002;126:686–91.
  • Anderson NS Turner L, Livingston S, Chen R, Nicosia SV, Kruk PA. Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluation. J Ovarian Res 2009;2:16.
  • Simstein R, Burow M, Parker A, Weldon C, Beckman B. Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system. Exp Biol and Med 2003;228:995–3.
  • Shilkaitis A, Graves J, Mehta RR, Hu L, You M, Lubet R, et al. Bcl-2 and Bax are differentially expressed in hyperplastic, premalignant, and malignant lesions of mammary carcinogenesis. Cell Growth Differ 2000;11:437–45.
  • Findley HW, Gu L, Yeager AM, Zhou M. Expression and regulation of Bcl-2, Bcl-xl, and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia. Blood 1997;89:2986–93.
  • Hong MY, Chapkin RS, Davidson LA, Turner ND, Morris JS, Carroll RJ, et al. Fish oil enhances targeted apoptosis during colon tumor initiation in part by downregulating Bcl-2. Nutr Cancer 2003;46:44–51.
  • Hirose Y, Yoshimi N, Suzui M, Kawabata K, Tanaka T, Mori H. Expression of Bcl-2, Bax and Bcl-XL proteins in azoxymethane-induced rat colonic adenocarcinomas. Mol Carcinog 1997;19:25–30.
  • Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988;335:440–42.
  • Cardillo M, Berchem G, Tarkington MA, Krajewski S, Krajewski M, Reed JC, et al. Resistance to apoptosis and up regulation of Bcl-2 in benign prostatic hyperplasia after androgen deprivation. J Urol 1997;158:212–16.
  • Shafi G, Munshi A, Hasan TN, Alshatwi AA, Jyothy A, Lei DK. Induction of apoptosis in HeLa cells by chloroform fraction of seed extracts of nigella sativa. Cancer Cell Int 2009;9:29.
  • Simstein R, Burow M, Parker A, Weldon C, Beckman B. Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system. Exp Biol and Med 2003;228:995–3.
  • Schmitt E, Parcellier A, Ghiringhelli F, Casares N, Gurbuxani S, Droin N, et al. Increased immunogenicity of colon cancer cells by selective depletion of cytochrome C. Cancer Res 2004;64:2705–11.
  • Turk HF, Kolar SS, Fan YY, Cozby CA, Lupton JR, Chapkin RS. Linoleic acid and butyrate synergize to increase Bcl-2 levels in colonocytes. Int J Cancer 2011;128:63–71.
  • Hong MY, Chapkin RS, Davidson LA, Turner ND, Morris JS, Carroll RJ, et al. Fish oil enhances targeted apoptosis during colon tumor initiation in part by downregulating Bcl-2. Nutr Cancer 2003;46:44–51.
  • Diep QN, Touyz RM, Schiffrin EL. Docosahexaenoic acid, a peroxisome proliferator-activated receptor-alpha ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase. Hypertension 2000;36:851–55.
  • Gu Z, Suburu J, Chen H, Chen YQ. Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention. BioMed Research International 2013;2013:824563.
  • Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993;75:241–51.
  • Albrecht H, Tschopp J, Jongeneel CV. Bcl-2 protects from oxidative damage and apoptotic cell death without interfering with activation of NF-kappa B by TNF. FEBS Lett 1994;351:45–48.
  • Serini S, Fasano E, Piccioni E, Monego G, Cittadini AR, Celleno L, et al. DHA induces apoptosis and differentiation in human melanoma cells in vitro: Involvement of HuR-mediated COX-2 mRNA stabilization and beta-catenin nuclear translocation. Carcinogenesis 2012;33:164–73.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.